Search

Des chercheurs ont suggéré que la psilocybine, un composé actif des champignons hallucinogènes, pourrait protéger les patients sous chimiothérapie des effets secondaires tels que la neuropathie périphérique, et un essai clinique à cet effet sera lancé à l'automne par le centre de cancérologie de l'université du Texas MD Anderson. #Psilocybine #Chimiothérapie #NeuropathiePeriphérique

Článek Jiřího Horáčka upozorňuje na blížící se dostupnost léčby psychedeliky, jako je psilocybin, pro pacienty trpící depresemi a závislostmi, která se vrací do medicíny díky novým studiím potvrzujícím její výraznou efektivitu ve srovnání s tradičními antidepresivy. #psilocybin #psychedelika #deprese #dobrezpravy

Psylocybina w terapii opornej na leczenie depresji. W małym, obserwacyjnym badaniu przeprowadzonym w Szwajcarii, psilocybina podawana w kontrolowanych warunkach klinicznych wiązała się ze zmniejszeniem nasilenia objawów depresji opornej na leczenie. https://t.co/rgEWPRfv62 #psylocybina #depresja #terapia #CH

Dans son livre innovant, la neuropsychiatre Caroline Depuydt explore le potentiel thérapeutique des psychédéliques, tels que la psilocybine et le LSD, dans le traitement de la dépression, des traumatismes et des addictions, soulignant un débat émergent sur leur utilisation médicale en Belgique, où ils sont actuellement interdits. #Psychédéliques #Thérapie #SantéMentale

Ein über 80-jähriger Alzheimer-Patientin erlebte nach der Einnahme von Psilocybin überraschende Verbesserungen, indem sie zu kommunizieren begann und familiäre Beziehungen erkannte, was die Forschungen zur Wirkung von Magic Mushrooms auf neurologische Erkrankungen unterstützt. #Psilocybin #Alzheimer #Demenz

Der Artikel beleuchtet die potenziellen therapeutischen Vorteile von Psychedelika wie LSD und Psilocybin als alternative Behandlungsmethoden für psychische Erkrankungen, während gleichzeitig wichtige Fragen zur Sicherheit und Wirksamkeit dieser Substanzen im Kontext von persönlichen Erfahrungsberichten thematisiert werden. #Psychedelika #Therapie #Psilocybin

Nová studie zveřejněná v JAMA Network Open naznačuje, že psilocybin, přírodní psychoaktivní látka, může být účinný při léčbě závislosti na kokainu, když je podáván v kombinaci s terapeutickými sezeními, což umožňuje pacientům změnit škodlivé návyky a zvyšuje pravděpodobnost, že se vzdají užívání této silně návykové drogy. #psilocybin #závislost #psychoterapie #dobrezpravy

Eine einmalige Dosis der psychedelischen Substanz Psilocybin hat in einer Studie des Karolinska-Instituts gezeigt, dass sie innerhalb weniger Tage zu einer signifikanten Linderung depressiver Symptome führen kann, wobei die positiven Effekte bis zu drei Monate anhielten. #Psilocybin #Depressionen #Psychedelika

Psychedelic-assisted therapy, particularly using compounds like psilocybin, presents a promising new treatment avenue for individuals with treatment-resistant mental illnesses, driven by significant research advancements, although legal and social stigmas pose challenges to its mainstream acceptance and accessibility. #MentalHealth #PsychedelicTherapy #DepressionTreatment #UK #US

Research indicates that psychedelic-assisted therapy, particularly using psilocybin, may offer new and effective treatment options for individuals struggling with treatment-resistant mental illnesses, as experts push for mainstream acceptance despite existing legal and social stigmas. #MentalHealth #Psychedelics #Therapy #UK #US

Amid a growing mental health crisis, research into psychedelic-assisted therapy, particularly with psilocybin, shows promise for treating resistant conditions like depression and PTSD, despite challenges such as legal status and social stigma. #MentalHealth #PsychedelicTherapy #PTSD #GB

In the face of a growing mental health crisis, research into psychedelic-assisted therapy, particularly using compounds like psilocybin, shows promising potential as a groundbreaking treatment option for those with treatment-resistant mental illnesses, though legal and social stigmas still pose significant hurdles to widespread acceptance and implementation. #MentalHealth #Psychedelics #Therapy #GB

In response to the escalating mental health crisis, research into psychedelic-assisted therapy, particularly involving psilocybin, shows promise as a potential treatment for resistant conditions like depression and PTSD, though significant legal and social stigma challenges remain before they can be widely approved and accessible. #MentalHealth #PsychedelicTherapy #PTSD #UK

Research suggests that psychedelic-assisted therapy, such as psilocybin treatment for mental health disorders like depression and PTSD, may offer new hope for patients resistant to traditional treatments, although legal and stigma-related challenges remain obstacles to widespread adoption. #MentalHealth #PsychedelicTherapy #PsychiatricResearch #UK

Amid the escalating mental health crisis, experts suggest that psychedelic-assisted therapy, particularly using psilocybin, could provide promising new treatment options for individuals suffering from conditions like depression and PTSD, though legal barriers and societal stigma still pose significant challenges to their approval and accessibility. #MentalHealth #PsychedelicTherapy #InnovativeTreatment #GB #US #CA

In the face of a growing mental health crisis, research indicates that psychedelic-assisted therapy, particularly using substances like psilocybin, may offer new hope for individuals with treatment-resistant mental illnesses such as depression and PTSD, though challenges like legal restrictions and societal stigma remain significant barriers to widespread acceptance and implementation. #MentalHealth #Psychedelics #Therapy #UK

In light of the ongoing mental health crisis, research is increasingly focusing on psychedelic-assisted therapy, particularly psilocybin, as a promising treatment for conditions like depression and PTSD, with expectations of FDA approval on the horizon, although challenges such as legal restrictions and societal stigma continue to hinder broader acceptance and research. #MentalHealth #Psychedelics #Therapy #GB

En engångsdos av psilocybin har visat sig ge snabb och kliniskt meningsfull lindring av depressiva symtom hos patienter med medelsvår till svår depression, enligt en ny studie från Karolinska Institutet, med effekter som kvarstod i över tre månader. #psilocybin #depression #psykedelia